Contact information
Type
Scientific
Primary contact
Dr David Schriger
ORCID ID
Contact details
924 Westwood Blvd Suite 300
Los Angeles
CA
90024-2924
United States of America
+1 310 794 0593
schriger@ucla.edu
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
N/A
Study information
Scientific title
Acronym
UCLA PRIME MD-2
Study hypothesis
Not provided at time of registration.
Ethics approval
Not provided at time of registration.
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Hospitals
Trial type
Diagnostic
Patient information sheet
Condition
Depression, anxiety and other psychiatric conditions
Intervention
Patients take the computerized PRIME-MD in the ED waiting room. They are randomized to three groups: PRIME-MD results shared with no one, shared with the patient only, or shared with the patient and the treating ED physician.
Low cost/no cost psychiatric referral sheet made available in the ED.
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measure
Not provided at time of registration.
Secondary outcome measures
Not provided at time of registration.
Overall trial start date
01/03/2002
Overall trial end date
01/09/2002
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
ED patients who present with a somatic (non-psychiatric) complaint that is of long duration, is chronic, or is not of a severity to warrant emergency care.
Resident physicians in Emergency Medicine and their faculty.
Participant type
Patient
Age group
Not Specified
Gender
Not Specified
Target number of participants
Not provided at time of registration.
Participant exclusion criteria
Not provided at time of registration.
Recruitment start date
01/03/2002
Recruitment end date
01/09/2002
Locations
Countries of recruitment
United States of America
Trial participating centre
924 Westwood Blvd Suite 300
Los Angeles, CA
90024-2924
United States of America
Funders
Funder type
Industry
Funder name
The Pfizer Corporation provided a $60,000 gift (not grant) in support of this research.
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Basic results (scientific)
Publication list
Results in: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15882462
Publication citations
-
Results
Schriger DL, Gibbons PS, Nezami WA, Langone CA, Failure of a patient-centered intervention to substantially increase the identification and referral for-treatment of ambulatory emergency department patients with occult psychiatric conditions: a randomized trial [ISRCTN61514736]., BMC Emerg Med, 2005, 5, 1, 2, doi: 10.1186/1471-227X-5-2.